Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01-MedSci.cn

Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01

Ahn, MJ; Lisberg, A; Paz-Ares, L; Cornelissen, R; Girard, N; Pons-Tostivint, E; Baz, DV; Sugawara, S; Dols, MC; Pérol, M; Mascaux, C; Poddubskaya, E; Kitazono, S; Hayashi, H; Sands, J; Hall, R; Zhang, Y; Zebger-Gong, H; Uema, D; Okamoto, I

ANNALS OF ONCOLOGY, 2023; 34 (): S1305

科室
- - 订阅+
  - 更多科室
工具
服务